JENNIFER ASMUS: Open Payments
NPI 1033542451 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $106 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $171 |
| Janssen Biotech, Inc. | 3 | $153 |
| ABBVIE INC. | 2 | $110 |
| Lundbeck LLC | 1 | $99 |
| TG Therapeutics, Inc. | 1 | $50 |
| Lilly USA, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Leqembi, QULIPTA, VYEPTI, BRIUMVI, KISUNLA, REXULTI.
Industry payments across NE — which companies pay providers there.
